SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Given Imaging (GIVN) -- Ignore unavailable to you. Want to Upgrade?


To: Tom Caruthers who wrote (14)10/7/2005 8:31:37 AM
From: telephonics  Respond to of 29
 
PillCam™ SB Video Capsule

-New capsule features latest innovations from Micron Technology and Zarlink Semiconductor -

Yoqneam, Israel; Boise, Idaho; Ottawa, Canada; October 6, 2005 -- Given Imaging, Ltd. (NASDAQ: GIVN), Micron Technology (NYSE: MU) and Zarlink Semiconductor (NYSE/TSX: ZL) announced today that they are finalizing development of a third generation PillCam SB ™ for the small bowel. The new capsule is expected to be commercially available in 2006.

Doubling the frame rate from two to four frames (images) per second, the new PillCam SB will offer enhanced viewing capacity while increasing the capsule's operational time from eight to nine hours and incorporate new optical and image sensor technology to provide superior image quality. Coupled with Given Imaging's latest RAPID software platform, the new PillCam SB capsule is designed to provide the physician with more detailed and extensive information to improve diagnostic efficacy as well as user friendliness and efficiency.
Micron's complementary metal-oxide semiconductor (CMOS) image sensors and Zarlink's ultra low-power RF (radio frequency) transmitter chips are used in Given's PillCam SB video capsule and PillCam™ ESO for imaging the esophagus as well as the future PillCam COLON, which is currently in clinical trials.



To: Tom Caruthers who wrote (14)10/7/2005 8:35:25 AM
From: telephonics  Respond to of 29
 
Correct. For the first time the Gastroenterologist has available a diagnostic tool that addresses small bowel problems. Previously exploratory surgery had to be resorted to in the more difficult cases. Spreading appreciation by insurance industry will aid in gaining reasonable compensation consideration.